Constitutive loss of transcription factor GATA-2 leads to embryonic lethality from primitive erythropoietic failure. We serendipitously discovered an essential contribution of GATA-2 to urogenital development when the hematopoietic deficiency of Gata2 null mutant animals was complemented by a Gata2 yeast artificial chromosome (YAC) transgene; these mice died from a perinatal lethal urogenital abnormality. Here, we report the generation and analysis of Gata2 hypomorphic mutant (Gata2fGN/fGN) mice, which suffered from hydronephrosis and megaureter, as do the YAC-rescued Gata2 null mutants. Gata2fGN/fGN mutants exhibit anteriorly displaced ureteric budding from the Wolffian duct as well as reduced BMP4 expression in the intermediate mesoderm derivatives in a manner that is temporally coincident with ureteric bud emergence. In Bmp4 mutant heterozygotes, rostral displacement of the initial bud site on the Wolffian duct results in abnormal urogenital development. We show here that Bmp4 mRNA is reduced approximately twofold in Gata2fGN/fGN mice (as in Bmp4 null heterozygotes), and that GATA-2 trans-activates a Bmp4 first intron element-directed reporter plasmid in co-transfection assays. These experiments taken together implicate GATA-2 as a direct regulator of Bmp4 transcription. The pathophysiology described in Gata2 hypomorphic mutant animals resembles human congenital anomalies of the kidney and urinary tract.
The GATA factors belong to an evolutionarily conserved family of transcription factors that play demonstrably critical roles in development (Patient & McGhee 2002). The DNA binding activity of the GATA factors is facilitated by two C4-type zinc fingers, which recognize the consensus sequence 5′ (A/G)GATA(A/T) 3′ (Ko & Engel 1993; Merika & Orkin 1993). In vertebrates, Gata2 is expressed in numerous cell lineages. Since the cloning of GATA-2 (Yamamoto et al. 1990), its functional role in hematopoiesis has been the focus of most investigations, particularly because Gata2 loss-of-function mutation leads to a reduced number of early hematopoietic progenitor cells, and consequently the Gata2 null mutants die at embryonic day (E) 10.5 from a failure in primitive erythropoiesis (Tsai et al. 1994).
The prominent participation of GATA-2 in urogenital patterning was serendipitously discovered when we attempted to complement the hematopoietic deficiency in Gata2 null embryos with a transgenic yeast artificial chromosome (YAC) encoding Gata2 (Gata2−/–::TgG2YAC). The 271 kbp d16B YAC, which spans –198 to +73 kbp of the Gata2 locus, restored full hematopoietic competence in Gata2−/−::TgG2YAC embryos, thus overcoming the hematopoietic deficiency and the resultant embryonic lethality attributed to GATA-2 deficit (Zhou et al. 1998; Khandekar et al. 2004). However, the YAC-rescued compound mutant animals succumbed to a urogenital disorder, leading to fully penetrant perinatal lethality. These neonates suffered from megaureter and hydronephrosis due to a developmental failure to generate a patent distal ureter–bladder connection (Zhou et al. 1998). Histological analyses reveal that the dilated ureters ended blindly or were aberrantly connected to the seminal vesicle or vas deferens, both Wolffian duct derivatives. More recently, we identified two Gata2 urogenital enhancers located far 3′ to the Gata2 structural gene (at +75 and +113 kbp with respect to the translation initiation site), both located beyond the boundaries of the d16B YAC (Khandekar et al. 2004). When cis-linked to a lacZ reporter gene, these enhancers reproduced the mesenchymal expression of endogenous GATA-2 in the developing urogenital system. At E10.5, Gata2 expression is initiated in the nephrogenic mesenchyme and the cloaca, but is specifically excluded from the epithelial Wolffian duct and mesonephric tubules (Khandekar et al. 2004). At E12.5, GATA-2 expression continues in the mesenchymal cells enveloping the Wolffian duct, the branching ureteric bud, the urogenital sinus as well as the ureteric epithelium (Khandekar et al. 2004). Later on, GATA-2 expression is activated in the Wolffian duct and its derivatives. This expression pattern remains throughout embryogenesis (Khandekar et al. 2004).
To further explore GATA-2 function and regulation in vivo, we generated in this study a conditional, marked Gata2 knock-in allele, so as to facilitate the eventual temporally- and tissue-specific elimination of GATA-2 function. In this flox-Gata2-Neo (Gata2fGN) conditional allele, a flag-tagged Gata2 cDNA and a PGK-neomycin cassette were inserted into the murine Gata2 locus. This insertional disruption of the locus leads to severely diminished Gata2 transcription in Gata2fGN/fGN animals. We found that, of the live Gata2fGN/fGN animals born, approximately 70% died within 1 month after birth of urological complications such as hypoplastic kidneys, hydronephrosis and megaureters, clearly resembling the phenotypic spectrum of YAC-rescued Gata2 null mutants (Zhou et al. 1998). We further determined that in the Gata2fGN/fGN embryos, the ureteric bud sprouted from a more rostral position on the Wolffian duct in comparison to wild-type littermates. This pre-cocious ureteric budding was accompanied by reduced urogenital BMP4 expression. BMP4, a member of the TGFβ superfamily of secreted signaling ligands, participates in various cell processes (including cell proliferation, differentiation and survival) and is necessary for the morphogenesis of many organs and tissues (Hogan 1996). We further showed that forcibly expressed GATA-2 can activate, albeit weakly, GATA-binding motifs in the Bmp4 first intron regulatory element. These data are consistent with previous reports of urological aberrations that develop in Bmp4 heterozygotes and arise from aberrantly localized ureteric bud (Miyazaki et al. 2000). Perhaps most importantly, the developmental pathophysiology detected in these Gata2 hypomorphic mutant animals strongly resembles human congenital anomalies of the kidney and urinary tract (CAKUT). CAKUT accounts for most chronic renal failures in children and encompass diseases with a wide anatomical spectrum, including kidney anomalies (renal agenesis, renal hypoplasia and renal dysplasia), ureteropelvic and ureterovesical junction anomalies, ectopic ureteral orifice, duplicated collecting system and anomalies of the bladder and urethra. Here, we demonstrate that transcription factor GATA-2 and its downstream target, BMP4, are amongst the genes that can give rise to the entire phenotypic spectrum of human CAKUT in mice (Ichikawa et al. 2002).
Generation of mice bearing a Gata2 conditional knockout allele
Previously, it was demonstrated that germ line ablation of Gata2 led to embryonic lethality at E10.5, a phenotype attributable to defective hematopoiesis in Gata2 null embryos (Tsai et al. 1994). This mid-gestational lethality hampered further exploration of the role of GATA-2 in the many other non-hematopoietic tissues that express GATA-2. In order to investigate GATA-2 contributions to other aspects of murine development, we generated a murine Gata2 conditional knockout allele. Gata2 transcription initiates from two alternative promoters (IS and IG) and their associated non-coding first exons (Minegishi et al. 1998; Nony et al. 1998). While the Gata2 IG promoter is widely utilized, the IS promoter is used only in hematopoietic and neuronal cells (Minegishi et al. 1998). A targeting vector was constructed in which part of exon 2 (containing the translational initiation codon) was replaced by a flag-tagged murine Gata2 cDNA and a Neo transcription cassette that was oriented in reverse of the Gata2 gene (Fig. 1A). The Gata2 cDNA and the Neo cassette were flanked on either side by loxP sequences to facilitate later selective excision by Cre-mediated homologous recombination (Fig. 1A).
The targeting construct was transfected into E14 embryonic stem (ES) cells, and targeted clones were enriched by positive/negative selection using Diphtheria toxin and growth medium containing G418 (Thomas & Capecchi 1987; Yagi et al. 1993). Successful homologous recombination in several ES cell clones was confirmed by Southern blotting (data not shown). Of these, two clones were used for injection into C57Bl/6 blastocysts, which were then implanted into foster mothers. Chimeric mice derived from both clones were intercrossed with C57Bl/6 mice, and F1 progeny were genotyped by Southern blotting. Using a radiolabeled probe corresponding to Gata2 exon 3, we detected an expected 10.6 kbp fragment in wild-type animals (Fig. 1B, lane 1) and two additional fragments (3.3 and 4.5 kbp) from the modified flox-Gata2-Neo (Gata2fGN) allele in heterozygous mutant animals (Fig. 1B, lane 2).
Urologic abnormalities, lower viability and body weight in Gata2fGN/fGN mice
Gata2fGN/+ mice were born without apparent abnormalities, and reproduced normally. However, a fraction of Gata2fGN/fGN pups generated from Gata2fGN/+ intercrosses died perinatally (Fig. 2A). To determine the onset of lethality, we examined multiple litters of Gata2fGN/+ intercrosses at gestational ages ranging from E14.5 to E18.5. Gata2fGN/fGN embryos began to die during late gestation, beginning around E17.5 (Fig. 2A). When we compared the viability curve of surviving Gata2fGN/fGN and wild-type animals during the first 30 days after birth, we found that approximately 50% of Gata2fGN/fGN pups died during the first 2 days after birth, and that the viability of Gata2fGN/fGN neonates continued to diminish gradually over the next 4 weeks (Fig. 2B).
Compared to wild-type littermates, only 30% of Gata2fGN/fGN pups lived more than 1 month beyond birth (Fig. 2B). Gata2fGN/fGN pups were generally smaller in size and were easily distinguishable from Gata2 heterozygous and wild-type littermates even at 1-week old (Fig. 2C). Both male and female Gata2fGN/fGN animals continued to show significantly lower body weights compared to their wild-type counterparts during the first 30 days after birth (Fig. 2D).
Previously, we reported that unlike Gata2 null mutant embryos, YAC-rescued Gata2 null animals overcame the initial cause of embryonic death at E10.5 due to hematopoietic failure (Tsai et al. 1994; Zhou et al. 1998). However, the rescued animals succumbed to a urogenital disorder, leading to perinatal lethality with full penetrance (Zhou et al. 1998). The compound mutant neonates suffered from megaureters and hydronephrosis as a result of fluid-filled dilatation of the ureters and kidneys (Zhou et al. 1998). Hence, the Gata2 YAC transgene was unable to recapitulate endogenous GATA-2 expression in the developing urogenital system (Zhou et al. 1998). We therefore wished to determine if the observed lethality in Gata2fGN/fGN mice was due to a related fatal urological disorder.
We performed gross examination on wild-type (N= 24), Gata2fGN/+ (N = 57) and Gata2fGN/fGN (N = 21) neonatal littermates from several litters, and found that 57% (12/21) of the Gata2fGN/fGN mutants displayed urological anomalies, including hypoplastic kidneys, hydronephrosis and megaureters (Fig. 3A). Although the severity of the urological phenotype was variable amongst the Gata2fGN/fGN animals, the most frequently encountered phenotype was uni- or bi-lateral megaureter (Fig. 3B). As with the YAC-rescued Gata2 null mutants, we did not observe duplicated or bifurcated ureters in Gata2fGN/fGN animals. Compared to wild-type animals, the size of kidneys in Gata2 mutant pups varied over a wide range (Fig. 3C), and was directly correlated with the severity of hydronephrosis, ranging from small, hypoplastic kidneys with mild cases of hydronephrosis (Fig. 3E) to enormously dilated kidneys in severe cases (Fig. 3F). In most instances, the renal parenchyma in the mutant kidneys was thinner than that in normal littermates (Fig. 3D vs. Fig. 3E and F). Hence, Gata2fGN/fGN mice suffered from urologic abnormalities that resemble aspects of human CAKUT.
There are multiple examples in the literature describing the disruption of transcription due to the targeted insertion of a selection cassette that resulted in the generation of a hypomorphic allele (e.g. Takahashi et al. 1997). We thus explored the possibility that the urogenital hypo/dysplasia observed in Gata2fGN/fGN animals could be due to reduced GATA-2 accumulation in the developing urogenital system. We dissected the intermediate mesoderm derivatives (containing the mesonephros, the metanephric anlagen, the Wolffian duct and the developing gonads) en bloc from individual E10.5 Gata2fGN/fGN and wild-type embryos for total RNA isolation. We then examined the mRNA abundance of Gata2 and Hprt, which served as an invariant control, by semi-quantitative RT-PCR. These data show that urogenital Gata2 mRNA abundance in E10.5 Gata2fGN/fGN mutants (4/4) was reduced to approximately 1.5% of wild-type levels (Fig. 3F and data not shown). We surmise that the Neo minigene positive selection cassette, which was cloned in the opposite transcriptional orientation with respect to the inserted Gata2 cDNA as well as the endogenous Gata2 allele, embedded in the targeted Gata2 locus severely reduced Gata2 transcription, thereby leading to the observed urologic phenotype in Gata2fGN/fGN mutants. This hypothesis is supported by the observation that mice hemizygous for a Gata2-gfp knock-in null allele (Suzuki et al. 2006) and the Gata2 conditional allele with the Neo minigene deleted are normal (R. Shimizu and M. Yamamoto, personal communication).
GATA-2 regulates the urogenital expression of BMP4
The advent of gene targeting technology has dramatically augmented our knowledge of genes that are essential for urogenital patterning. Germ line mutagenesis of Foxc1/2, Bmp4 and Rar α/β leads to the formation of hypo/dysplastic kidneys, hydronephrosis and megaureters in mutant mice as a consequence of multiple ureteric buds, anteriorly displaced ureteric buds or defective distal ureter maturation, respectively (Mendelsohn et al. 1994, 1999; Kume et al. 2000; Batourina et al. 2002). The latter process requires the GDNF/c-ret signaling pathway in the caudal Wolffian duct and the urogenital sinus (Batourina et al. 2002), where GATA-2 is also expressed (Khandekar et al. 2004). We were interested to determine if transcription of any of these genes were affected in Gata2fGN/fGN embryos, thereby placing some conceptual constraints on possible epistatic interactions between GATA-2 and these effectors. We prepared total RNA from the intermediate mesoderm derivatives of several individual E10.5 wild-type and Gata2fGN/fGN embryos for analysis using semi-quantitative RT-PCR. We found that the mRNAs levels of Rar (α, β and γ), Foxc1, Foxc2 and Gdnf were unaffected in Gata2fGN/fGN embryos (Fig. 4A). This is consistent with the recent observation of continued expression of Foxc1 and Foxc2 in GATA-2-deficient lymphatic endothelial cells (S. Dagenais and K.-C. Lim, personal communication; Khandekar et al. 2007).
We also examined Bmp4 transcript levels in total RNA prepared from the intermediate mesoderm derivatives of E10.5 wild-type and Gata2fGN/fGN embryos using semi-quantitative RT-PCR. The abundance of BMP4 mRNA was reduced in Gata2fGN/fGN embryos in comparison to wild-type embryos (Fig. 4B). This result was verified by real-time RT-PCR: Bmp4 transcript level in Gata2fGN/fGN embryos was approximately half of that detected in wild-type embryos (Fig. 4C). We also analyzed the mRNA levels of the BMP4 receptor, Alk3, but failed to detect a change (Fig. 4A).
It was previously reported that proper ureteric budding requires the secreted morphogen BMP4, which is expressed in the urogenital mesenchyme surrounding the Wolffian duct and the ureteric stalk (Dudley & Robertson 1997; Miyazaki et al. 2000; Michos et al. 2007). Anti-GFP immunostaining on transverse sections of E11.0 Gata2-GFP knock-in heterozygous embryos (Suzuki et al. 2006) indicated that the GFP immunostaining pattern in the urogenital mesenchymal cells surrounding the ureteric bud and the Wolffian duct (Fig. 4D and data not shown; Khandekar et al. 2004), resembling that of BMP4. Thus, significant loss of GATA-2 expression in Gata2fGN/fGN embryos led to reduced Bmp4 expression in the urogenital mesenchyme, which in turn resulted in rostrally displaced ureteric outgrowth on the Wolffian duct. Thus, the data presented here implicate GATA-2 as a (direct or indirect) positive regulator of Bmp4 transcription.
Ectopic ureteric bud position in Gata2fGN/fGN mice
The development of the metanephros begins with the outgrowth of a single ureteric bud from the posterior Wolffian duct at E10.5 of mouse embryogenesis (Costantini & Shakya 2006). This positional restriction of ureteral budding to a specific caudal segment of the Wolffian duct is critical as dysregulation of initial ureteric bud formation leads to CAKUT (Ichikawa et al. 2002). Previously, it was reported that 53% of Bmp4+/– mice exhibited CAKUT symptoms due to the formation of a cranially positioned ureteric bud (Miyazaki et al. 2000). We thus investigated whether aberrant ureteral budding occurred in Gata2fGN/fGN mice. E11.0 wild-type (N = 5), Gata2fGN/+ (N = 5) and Gata2fGN/fGN (N = 10) embryos were subjected to in situ hybridization using c-ret and shh antisense probes. c-Ret is a receptor tyrosine kinase for the secreted growth factor GDNF, and its expression in the urogenital system is restricted to the epithelial nephric duct and ureteric bud (Dressler 2006), while sonic hedgehog (Shh) is a morphogen that is expressed in numerous tissues, including the somites (Ingham & McMahon 2001).
When we analyzed the embryos after in situ hybridization to both probes, we noted that in wild-type and Gata2fGN/+ embryos, the position of the initial ureteric budding site aligned with the 26th somite (Fig. 5A), as previously reported (Miyazaki et al. 2000). However, in 50% of the Gata2fGN/fGN embryos, ureteral budding initiated more anteriorly along the Wolffian duct, at an axial position corresponding to the 25th somite (Fig. 5B). This frequency correlated well with our earlier observation that 57% of Gata2fGN/fGN neonates exhibited some uropathy upon gross examination (Fig. 3A). These observations indicate that normal GATA-2 abundance is important for providing positional information for initial ureteric bud outgrowth along the Wolffian duct.
GATA-2 can trans-activate a Bmp4 first intron regulatory element
Several consensus GATA-binding sites present in the Bmp4 promoter and second intron are conserved across six mammalian species (Nemer & Nemer 2003; Thompson et al. 2003; Lugus et al. 2007). The in vivo occupancy of both elements (as demonstrated by chromatin immunoprecipitation analysis) and their functional importance in the Bmp4 promoter has been shown in embryoid bodies and cardiomyocytes (Nemer & Nemer 2003; Lugus et al. 2007). The Gata2 hypomorphic mutation could directly or indirectly affect Bmp4 mRNA levels in Gata2fGN/fGN embryos. We attempted to address this question by evaluating GATA-2 activation potential on Bmp4 transcriptional activity in cell-based transfection assays using a 1.3-kbp Bmp4 Upstream fragment containing upstream GATA motifs and a part of the IA exon and a 1.8-kbp Intronic fragment containing a part of the IB exon, the entire first intron and II exon, and almost entire second intron in cotransfection transactivation assays (Fig. 6A). The Bmp4 Upstream fragment was cloned into a promoter-less luciferase reporter construct to generate Upstream-Luc reporter plasmid, while the Bmp4 Intronic fragment was inserted 5′ to an SV40 promoter-driven luciferase reporter construct to create Intronic-Luc reporter plasmid (Fig. 6B). Both reporter plasmids as well as their respective base vectors were transfected into QT6 quail fibroblast cells with or without a co-transfected GATA-2 expression vector.
We did not detect any change in luciferase activity associated with the 1.3 kbp Bmp4 promoter regardless of the presence of exogenous GATA-2 in transfected QT6 cells (Fig. 6C). However, in the presence of forcibly expressed GATA-2, luciferase activity linked to the intronic regulatory element was stimulated threefold over background (Fig. 6C). Thus, GATA-2 indeed activates Bmp4 transcription in this restricted setting. Taken together, the data support the hypothesis that the Bmp4 gene is a directly activated target of GATA-2 in the urogenital system and that GATA-2 activates Bmp4 through a partially characterized first intron element that contains two evolutionarily conserved GATA-binding sites.
GATA-2 plays several important roles in the determination and differentiation of numerous cell lineages during embryogenesis and systemic loss of GATA-2 leads to early embryonic lethality due to primitive erythropoietic deficiency (Tsai et al. 1994). In this study, we report that most Gata2 homozygous hypomorphic animals died within 1 month after birth due to urological complications typified by hypoplastic kidneys, hydronephrosis and megaureters, just as was seen in YAC-rescued Gata2 null animals. We further determined the morphogenetic and molecular events underlying these developmental aberrations.
During early renal morphogenesis, the correct emergence of a single ureteric bud from the posterior Wolffian duct is imperative to the development of a functioning urogenital system later in adulthood. The precision of this process is dictated by the combinatorial actions of both positive and negative regulatory molecules (Costantini & Shakya 2006). Homozygous loss of genes encoding slit2 or its receptor, robo2, or the forkhead/winged helix transcription factor Foxc1 and receptor tyrosine kinase antagonist sprouty1 as well as compound heterozygosity of Foxc1/2 null mutation lead to formation of supra-numeral ureteric buds as a consequence of expanding the anterior limit of the GDNF-positive mesenchymal domain within the intermediate mesoderm derivatives or of the elimination of inhibitory feedback on GDNF/c-ret signal transduction (Kume et al. 2000; Grieshammer et al. 2004; Basson et al. 2005). Indeed, excess GDNF alone in vitro and in vivo is sufficient to induce extra ureteral budding (Sainio et al. 1997; Brophy et al. 2001; Shakya et al. 2005). However, the stimulatory effect of GDNF on ureteral budding and branching can be abrogated by BMP4 (Raatikainen-Ahokas et al. 2000; Brophy et al. 2001). Furthermore, perturbations of BMP level/activity by germ line mutagenesis of BMP4 antagonist Gremlin1 (Michos et al. 2004, 2007), transgenic expression of a constitutively active BMP receptor, Alk3 (Hu et al. 2003) or haploinsufficiency of Bmp4 gene in Bmp4 heterozygous mutants (Miyazaki et al. 2000) lead to uropathies in each of these mutants, clearly underscoring the conclusion that homeostasis in BMP activity is critical for proper urogenital patterning. Exposure of cultured metanephric explants to Gemlin-1 or BMP4 does not affect GDNF expression (Miyazaki et al. 2000; Michos et al. 2007); therefore, how changes in BMP4 activity in the metanephric mesenchyme lead to aberrant ureteric budding in vivo remains to be deciphered.
In Gata2fGN/fGN mice, we observed that the ureteric bud emerged from an abnormally anterior position along the Wolffian duct; this was commensurate with twofold reduced BMP4 expression in the urogenital region, which is consistent with the report of urological aberrations observed in Bmp4 heterozygous knockout mice (Miyazaki et al. 2000). The ectopic budding of the ureteric bud leads to erroneous ureterovesical junction that later in development manifests as CAKUT (reviewed in Ichikawa et al. 2002). We recently ascertained that the same morphogenetic error occurred in YAC-rescued Gata2-null mutants (Zhou et al. 1998; K.-C. Lim, personal communication). We observed that almost an equivalent number of the Gata2 hypomorphic mutant animals displayed urologic abnormalities and ectopic ureteric budding (57% and 50%, respectively). In these animals BMP4 expression is reduced in the intermediate mesoderm derivatives. Examination of Bmp4 heterozygotes revealed a urogenital phenotype that resembles human CAKUT in 53% of the animals (Miyazaki et al. 2000). We also showed that GATA-2 could activate expression from a Bmp4 first intronic regulatory element-directed reporter gene in cell-based transfection assays, again underscoring the possibility that GATA-2 is an upstream regulator of BMP4 expression during urogenital development (Fig. 7). Further experimental evidence addressing this epistatic relationship in vivo might be achieved by manipulating BMP4 levels using the recently identified Gata2 urogenital enhancers UG2/4 (Khandekar et al. 2004) to drive BMP4 mesenchymal expression in Gata2fGN/fGN mice or by breeding the Gata2fGN allele into a Gremlin1-deficient genetic background (Michos et al. 2004).
The Gata2fGN/fGN mice generated here also displayed lower body mass. Using a αGSU-Cre transgene to achieve pituitary-specific GATA-2 loss-of-function, Charles et al. (2006) revealed reduced gonadotrophic and thyrotropic hormones in pituitary-specific Gata2 knockout (pitKO) mice. Male, but not female, pitKO mice initially showed lower body mass, but eventually they reached normal size. On the other hand, the growth retardation of the Gata2fGN/fGN mice is not sex-specific. This difference between the two Gata2 mutant mouse lines could be due to the strategy of Gata2 gene mutation. The αGSU-Cre transgene was shown to effectively convert a floxed SF1 allele to a non-functional allele by E14.5 (Zhao et al. 2001), and Gata2 transcription was reduced to 2%–8% of wild-type levels in pituitary glands of pitKO mice (Charles et al. 2006). The reduction of Gata2 transcripts was more drastic (< 1.5%) and systemic in Gata2fGN/fGN mice, and the spatiotemporal timing of GATA-2 loss was dictated by the endogenous targeted Gata2 locus. While the transient weight reduction in pitKO males was considered to be due to compromised thyrotropic function (Charles et al. 2006), the cause of growth retardation in Gata2fGN/fGN mice may not be explained solely by thyrotropic dysfunction since GATA-2 is widely expressed. Further experiments will be necessary to elucidate the cause of the growth retardation in Gata2fGN/fGN mice.
Previous studies suggested that BMP4 regulates Gata2 expression. In Xenopus, for example, injection of Bmp4 mRNA promoted Gata2 activation (Maeno et al. 1996). Furthermore, a BMP4 responsive element has been defined in the 5′ upstream region of zebrafish Gata2 (Oren et al. 2005). In contrast, the present data indicate that GATA-2 regulates urogenital BMP4 expression. Other investigators have also reported that other GATA factors (i.e. GATA-4 and GATA-6) regulate Bmp4 transcription, for example, in cardiomyocytes (Nemer & Nemer 2003; Peterkin et al. 2003, 2005). Consistent with this observation, GATA-binding motifs that are evolutionarily conserved across mammalian species have been identified in regulatory sequences controlling Bmp4 transcription (Nemer & Nemer 2003; Lugus et al. 2007). Furthermore, the occupancy of these GATA sites, particularly in the first intron of Bmp4, by GATA-2 was determined by chromatin immunoprecipitation assay in differentiating embryoid bodies (Lugus et al. 2007). It is interesting to note that the GATA-2/BMP4 relationship was suggested to be non-linear, in which case both factors could reciprocally modulate the expression of one another (Lugus et al. 2007). Given that the nearly complete loss of GATA-2 in Gata2fGN/fGN mice reduces, but does not abolish, BMP4 expression, we would surmise that GATA-2 is not the sole effector of Bmp4 transcription, but is required for maintenance of its transcript abundance. Regardless of the specific underlying mechanisms, the regulatory axis formed by GATA-2 and BMP4 clearly appears to be crucial for urogenital development, and elucidation of their roles in this developmental pathway may lead to a better understanding of this extremely common pediatric disease.
This experiment was approved by the Institutional Animal Experiment Committee and by the Regulation for Animal Experiments of the University of Tsukuba
Generation of Gata2 mice
The targeting construct was electroporated into E14 ES cells and then subjected to a positive and negative selection with DT and neomycin (300 µg/mL). ES cell colonies were isolated, expanded, and screened for homologous recombination by PCR and confirmed by Southern blot analyses. Isolated ES cells were injected into C57BL/6J blastocysts and then surgically implanted into pseudopregnant ICR foster mothers. Chimeric mice bearing the mutant flox-Gata2-Neo (Gata2fGN) allele were then intercrossed with C57BL/6J mice and the offspring were genotyped by PCR using primers that detect wild-type [5′-tggttcccaagacacagtagtgga-3′ (sense; s) and 5′-agtccctgcctccatcttcttagg-3′ (antisense; as)] or mutant [5′-aagtatccatcatggctgatgc-3′ (s) and 5′-tagccaacgctatgtcttgata-3′ (as)] alleles. Gata2fGN/+ mice were crossed with wild-type BDF1 mice for maintenance.
Gata2fGN/+ mice were intercrossed and the newborn progeny were analyzed for phenotypes. Dissected newborn kidneys were fixed in phosphate-buffered saline (PBS) containing 10% formaldehyde and then individually measured along their long and short axes using a micrometric grid. Kidneys were embedded in OCT compound (Sakura Finetechnical, Tokyo, Japan) and subsequently were sectioned into 7 µm slices for hematoxylin and eosin staining.
In situ hybridization analysis and immunohistochemistry
In situ hybridization was performed upon the method as described (Wilkinson & Nieto 1993). Briefly, digoxygenin-UTP labeled antisense riboprobes were prepared from shh template (generously provided by Dr Noji, University of Tokushima). The murine c-ret template was synthesized by PCR from embryonic RNA using primers 5′-acctgagtgcaccaagcttc-3′ (s) and 5′-cagctaagtcccgatgtacaagc-3′ (as). The amplified fragment was cloned into pGEM-T Easy Vector (Promega, Madison, WI), and c-ret antisense and sense riboprobes were synthesized using Sp6 and T7 polymerases. For whole mount photography, embryos were cleared in benzyl alcohol–benzyl benzoate (2 : 1).
Embryos (E11.0) were fixed in PBS containing 4% paraformaldehyde for 1.5 h at 4 °C and then equilibrated in 20% sucrose for 4 h prior to embedding in the OCT compound. For antibody staining, thin sections were treated with H2O2 and blocked with 2% skim milk, 1% goat serum and 0.25% bovine serum albumin in PBS. Purified rabbit anti-GFP antibody (1 : 1000) was then added and incubated overnight at 4 °C. The sections were incubated with HRP-conjugated goat anti-rabbit secondary antibody (1 : 500) at room temperature for 1 h. Color development was carried out using diaminobenzidine as chromogen.
Intermediate mesoderm derivatives (containing the mesonephros, the metanephric anlagen as well as the undifferentiated gonads) were dissected en bloc from individual E10.5 embryos for total RNA isolation using an Isogen RNA preparation kit (Nippon Gene, Tokyo, Japan). The cDNA samples were synthesized with Superscript II reverse transcriptase (Invitrogen, Carlsbad, CA). For semi-quantitative analyses, each cDNA was diluted so that the HPRT amplicons are equivalent amongst the test samples. Primers used were: Gata2 5′-tcaaccacttcgactcgcag-3′ (s) and 5′-cggtgacttctcttgcatgca-3′ (as); Bmp4 5′-ctcccaagaatcatggactg-3′ (s) and 5′-aaagcagagctctcactggt-3′ (as); Gdnd 5′-accagataaacaagcggcag-3′ (s) and 5′-tcagatacatccacaccgtttag-3′ (as); Alk3 5′-tgactcagctatacacttacatcag-3′ (s) and 5′-caggtctttcagtgattctcc-3′ (as); Foxc1 5′-gcggaaattgtaggagttccctag-3′ (s) and 5′-tttggcatctggctcacagg-3′ (as); Foxc2 5′-acgagtgcggatttgtaaccag-3′ (s) and, 5′-gtgtttttggaataccccagatgg-3′ (as); Rarα 5′-cagttccgaagagatagtacc-3′ (s) and 5′-tacaccatgttcttctggatgc-3′ (as); Rarβ 5′-tcgagacacagagtaccagc-3′ (s) and 5′-gaaaagcccttgcacccct-3′ (as); Rarγ 5′-gcctcctcgggtctacaag-3′ (s) and 5′-atgatacagtttttgtcgcgg-3′ (as); Hprt 5′-gctggtgaaaaggacctct-3′ (s), and 5′-cacaggactagaacacctgc-3′ (as).
Upstream and intronic regulatory fragments of Bmp4 gene were synthesized by PCR using mouse genomic DNA as a template. Primer sequences were 5′-ccctttgagagctacctgaa-3′ (s) 5′-cagagactggatcgctgca-3′ (as) for Upstream fragment and 5′-cggtttctgaaggatctgcttg-3′ (s) and 5′-tttcttcccggtctcaggtatc-3′ (as) for Intronic fragment. We generated two types of reporter plasmids for the luciferase assays. One reporter (Intronic-Luc) was generated by inserting a 1.8-kbp Bmp4 Intronic fragment (containing the a part of the IB exon, the entire first intron and II exon, and almost entire second intron) into the SacI site of pGL3 (Promega), while the other (Upstream-Luc) was generated by replacing the SV40 promoter of pGL3 with a 1.3-kbp fragment containing the mouse Bmp4 Upstream fragment (containing upstream GATA motifs and a part of the IA exon). The parental vectors, with or without the SV40 promoter, were used as the controls for Intronic-Luc and Upstream-Luc, respectively. QT6 cells were transfected with 0, 60 or 180 ng of pEF-GATA-2 expression vector together with 10 ng of reporter plasmids using Fugene 6 (Roche, Basel, Switzerland). pRL-TK (Promega) was co-transfected in every well to serve as an indicator of transfection efficiency. The total amount of DNA transfected in each well was adjusted to 200 ng with empty pEF vector. All luciferase assays were executed using the Dual-Luciferase reporter assay system according to the manufacturer's protocol (Promega) and normalized to Renilla luciferase activity.
This work was supported in part by research grants from Grants-in-aid from JST ERATO, and the Ministry of Education, Culture, Sports, Science and Technology of Japan (MY) and from the NIH (GM28896, JDE).